Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,...
Patent
1997-03-20
1999-07-06
Gulakowski, Randy
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
4241791, 4241941, 42419511, 4241931, 514449, 560182, 549433, 549510, 525 541, 525 5411, 525403, 525408, 530403, 530406, 530408, 530410, A61K 39395
Patent
active
059194553
ABSTRACT:
Branched, substantially non-antigenic polymers are disclosed. Conjugates prepared with the polymers and biologically active molecules such as proteins and peptides demonstrate extended circulating life in vivo. Substantially fewer sites on the biologically active material are used as attachment sites. Methods of forming the polymer, conjugating the polymers with biologically active moieties and methods of using the conjugates are also disclosed.
REFERENCES:
patent: 4101380 (1978-07-01), Rubinstein et al.
patent: 4179337 (1979-12-01), Davis et al.
patent: 4275000 (1981-06-01), Ross
patent: 4680338 (1987-07-01), Sundoro
patent: 4766106 (1988-08-01), Katre et al.
patent: 4846548 (1989-07-01), Klainer
patent: 4889916 (1959-12-01), Packard et al.
patent: 4904582 (1990-02-01), Tullis
patent: 5091176 (1992-02-01), Braatz et al.
patent: 5091542 (1992-02-01), Ahlem et al.
patent: 5093531 (1992-03-01), Sano et al.
patent: 5122614 (1992-06-01), Zalipsky
patent: 5183660 (1993-02-01), Ikeda et al.
patent: 5214131 (1993-05-01), Sano et al.
patent: 5217564 (1993-06-01), Zalipsky et al.
patent: 5229490 (1993-07-01), Tam
patent: 5252714 (1993-10-01), Harris et al.
patent: 5281698 (1994-01-01), Nitecki
patent: 5298643 (1994-03-01), Greenwald
patent: 5321095 (1994-06-01), Greenwald
patent: 5324844 (1994-06-01), Zalipsky
patent: 5349001 (1994-09-01), Greenwald et al.
patent: 5514379 (1996-05-01), Weissleder et al.
patent: 5543158 (1996-08-01), Gref et al.
patent: 5545698 (1996-08-01), Barany et al.
patent: 5643575 (1997-07-01), Martinez et al.
patent: 5681567 (1997-10-01), Martinez et al.
Bogdanov, A. et al. "A New Marcomolecule as a Contrast Agent for MR Angiography: Preparation, Properties, and Animal Studies" Radiology 187: 701-706 (1993) Mailed May 20, 1993.
Nishimura et al, Enzyme 26, pp. 49-53 (1981).
Kimura et al, Proceeding of the Society for Experimental Biology and Medicine, 188, pp. 364-369 (1988).
Zalipsky et al, Eur. Polym. J., vol. 19, No. 12, pp. 1177-1183, (1983).
Ouchi et al, Drug Design and Discovery, vol. 9, pp. 93-105 (1992).
Eur. Polym. J. vol. 19 No. 12.pp.1177-1183 (1983).
Biotechnology and Applied Biochemistry 9.258-268 (1987).
Journal of Controlled Release 10 (1989) 145-154 (1989).
Advanced Drug Delivery Reviews 6 (1991) 133-151.
Cancer Biochem. Biophys. (1984) vol. 7 pp. 175-186.
Polymer Bulletin 18, 487-493 (1987).
Journal of Polymer Science: Polymer Chemistry Edition, vol. 22 pp. 341-352 (1984).
Int. Arch Allergy Appl. Immun. 64:84-99 (1981).
The Journal of Biological Chemistry vol. 263, No. 29, Issue of Oct. 15, pp. 15064, 15070 (1988).
Wie et al (1981) Int. Arch. Allergy Appl. Immun, 64:84-99.
Savoca et al (1979) Biochim. Biophys. Acta 578:47-53.
Selvon (1991) Int. Arch. Allergy Appl. Immunol 94: 11-20.
Nucci et al (1991) Advances Drug Delivery Reviews 6:133-151.
Knauf et al., "Relationship of Effective Molecular Size . . . ," J Biol Chem 263:15064-70 (1988).
Nathan et al, "Polyethylene Glycol-Lysine Copolymers;," Polymer Preprints 31: 213-214 (199).
Greenwald Richard B.
Martinez Anthony J.
Enzon Inc.
Gulakowski Randy
LandOfFree
Non-antigenic branched polymer conjugates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non-antigenic branched polymer conjugates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-antigenic branched polymer conjugates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-897255